Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine binds to and results in increased activity of ADORA2A protein | affects binding|increases activity | 16793905
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
ADORA2A protein results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | increases response to substance | 11172060
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine binds to and results in increased activity of ADORA2A protein | affects binding|increases activity | 19966059 19749167 15452191
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA] | decreases reaction|increases expression | 19966059
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA]] | decreases reaction|increases expression | 19966059
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein]] | decreases reaction|increases expression | 19966059
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ADORA2A mRNA | affects expression | 21346803
|
C057837 |
3,7-dimethyl-1-propargylxanthine |
3,7-dimethyl-1-propargylxanthine binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 11023991
|
C098657 |
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine |
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 16793905
|
C098657 |
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine |
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 19749167
|
C081320 |
8-(3-chlorostyryl)caffeine |
ADORA2A protein results in increased susceptibility to 8-(3-chlorostyryl)caffeine | increases response to substance | 11172060
|
C081320 |
8-(3-chlorostyryl)caffeine |
8-(3-chlorostyryl)caffeine binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 19966059
|
C081320 |
8-(3-chlorostyryl)caffeine |
8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA]] | decreases reaction|increases expression | 19966059
|
C081320 |
8-(3-chlorostyryl)caffeine |
8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein]] | decreases reaction|increases expression | 19966059
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ADORA2A mRNA | affects expression | 17562736
|
D000109 |
Acetylcholine |
ADORA2A protein results in increased susceptibility to Acetylcholine | increases response to substance | 16616212
|
D000109 |
Acetylcholine |
ZM 241385 inhibits the reaction [ADORA2A protein results in increased susceptibility to Acetylcholine] | decreases reaction|increases response to substance | 16616212
|
D000241 |
Adenosine |
Adenosine results in increased activity of ADORA2A protein | increases activity | 16793905
|
C008436 |
adenosine 5'-methylenediphosphate |
adenosine 5'-methylenediphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA] | decreases reaction|increases expression | 19966059
|
C008436 |
adenosine 5'-methylenediphosphate |
adenosine 5'-methylenediphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
C523965 |
alpha,beta-methyleneadenosine 5'-diphosphate |
alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ADORA2A mRNA | affects expression | 16483693
|
D000661 |
Amphetamine |
ADORA2A gene polymorphism results in increased susceptibility to Amphetamine | increases response to substance | 16118787
|
D000661 |
Amphetamine |
ADORA2A protein affects the susceptibility to Amphetamine | affects response to substance | 16118787
|
D000661 |
Amphetamine |
ADORA2A protein affects the reaction [Amphetamine results in increased expression of PDYN mRNA] | affects reaction|increases expression | 12700712
|
D000661 |
Amphetamine |
ADORA2A protein results in increased susceptibility to Amphetamine | increases response to substance | 12700712
|
D002110 |
Caffeine |
ADORA2A protein results in increased susceptibility to Caffeine | increases response to substance | 11172060
|
D002110 |
Caffeine |
Caffeine analog binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 15452191
|
D002110 |
Caffeine |
Caffeine results in decreased expression of ADORA2A mRNA | decreases expression | 16771831
|
D002251 |
Carbon Tetrachloride |
ADORA2A gene mutant form results in decreased susceptibility to Carbon Tetrachloride | decreases response to substance | 16783407
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of ADORA2A mRNA | increases expression | 18263696
|
D003024 |
Clozapine |
Clozapine results in decreased expression of ADORA2A mRNA | decreases expression | 17266109
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in decreased expression of ADORA2A mRNA | decreases expression | 15620428
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of ADORA2A mRNA | decreases expression | 15620428
|
D004958 |
Estradiol |
Estradiol results in increased expression of ADORA2A mRNA | increases expression | 20068009
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of ADORA2A mRNA | increases expression | 18035473
|
D006220 |
Haloperidol |
ADORA2A protein affects the susceptibility to Haloperidol | affects response to substance | 11172060
|
C111599 |
istradefylline |
istradefylline binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 19467297
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of ADORA2A mRNA | increases expression | 16387843
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of ADORA2A protein | increases expression | 16387843
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of ADORA2A mRNA | increases expression | 16780908
|
D010269 |
Paraquat |
Paraquat affects the expression of ADORA2A mRNA | affects expression | 16854511
|
D010269 |
Paraquat |
Paraquat results in increased expression of ADORA2A mRNA | increases expression | 17077588
|
D010622 |
Phencyclidine |
Phencyclidine results in decreased expression of ADORA2A mRNA | decreases expression | 17266109
|
D010656 |
Phenylephrine |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA]] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
8-(3-chlorostyryl)caffeine inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein]] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
adenosine 5'-methylenediphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A mRNA] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
adenosine 5'-methylenediphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
ADORA2A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
alpha,beta-methyleneadenosine 5'-diphosphate inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of ADORA2A mRNA | increases expression | 19966059
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of ADORA2A protein | increases expression | 19966059
|
D010656 |
Phenylephrine |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA2A protein] | decreases reaction|increases expression | 19966059
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of ADORA2A mRNA | increases expression | 15849065
|
D013654 |
Taurine |
Taurine results in decreased expression of ADORA2A mRNA | decreases expression | 16579726
|
D013853 |
Thioacetamide |
ADORA2A gene mutant form results in decreased susceptibility to Thioacetamide | decreases response to substance | 16783407
|
D013853 |
Thioacetamide |
Thioacetamide results in increased expression of ADORA2A mRNA | increases expression | 16783407
|
C097270 |
ZM 241385 |
ZM 241385 binds to and results in decreased activity of ADORA2A protein | affects binding|decreases activity | 16616212
|
C097270 |
ZM 241385 |
ZM 241385 inhibits the reaction [ADORA2A protein results in increased susceptibility to Acetylcholine] | decreases reaction|increases response to substance | 16616212
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
4.28 | 6734493 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.26 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.58 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
8.58 | 11954676 12718980 16100012 19131640 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.03 | 11473722 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.77 | 16160616 14617031 12649775 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.47 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.31 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.48 | 15800139 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.76 | 18475255 16916582 16459022 15010207 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.54 | 10982225 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
4.76 | 12183048 16101753 16084549 12005258 |
MESH:D001008 |
Anxiety Disorders |
marker/mechanism |
|
| 16118787 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.86 | 17460149 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.40 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Adenosine |
2.40 | 20468076 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.40 | 19368416 18080171 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
3.91 | 19483382 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.25 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.19 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.34 | 17261762 18497071 19861407 17018787 16675129 14630087 17289903 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.34 | 17440819 16912660 17261762 15572757 15758505 17893378 17049068 16837676 17952589 17595753 15775269 17242785 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.17 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.49 | 15700767 16124888 15673190 16097048 3786805 16011737 16227642 18705752 15721981 16192424 10355542 16050911 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.31 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.31 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.31 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.31 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
8.31 | 17997003 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
3.82 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
3.37 | 11754973 16170337 17124262 17287366 15728586 11179087 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.24 | 15775269 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.61 | 1977408 15215559 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.41 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.57 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
4.04 | 18291259 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
10.72 | 17123785 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
10.72 | 15800139 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
5.17 | 16037377 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.73 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.57 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.32 | 11575062 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.92 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.40 | 16780908 11298694 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
3.91 | 16882537 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.90 | 16402076 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
5.76 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.19 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.19 | 17308373 17451421 15920148 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.25 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
14.07 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.07 | 10774834 19416960 16177239 11461765 16393943 11287661 16781746 10663392 17522070 18713872 14725611 17906064 19370779 19739265 16081117 12153990 12392966 10915739 12958197 18071297 12705907 19420014 16109766 12540782 11421492 19923254 16227642 2444490 14986274 15619225 19085960 11739529 15968718 19164858 16485898 11743745 17562736 12594235 11834606 14550746 11529661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
14.07 | 16177239 7179309 15968718 10092053 2869522 6884620 19085960 19336974 21278145 3786805 10915739 3732212 15998439 7120509 4309450 15027814 16227642 7440962 6623471 9327722 17522070 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
14.07 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
14.07 | 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
14.07 | 12963478 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.80 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.97 | 16402076 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.09 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
3.72 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.79 | 11473722 19148513 18566989 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.10 | 17637181 15328337 15821434 |
MESH:D004827 |
Epilepsy |
|
Adenosine |
4.65 | 11404469 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
5.30 | 19890266 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.42 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.12 | 16045604 15959796 12795759 17595544 12631006 16239168 61145 19224547 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
7.12 | 17473493 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.76 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.17 | 18705752 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.38 | 16983495 |
MESH:D005910 |
Glioma |
|
alpha,beta-methyleneadenosine 5'-diphosphate |
5.19 | 17643826 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.86 | 11124998 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.33 | 11110106 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.13 | 16366002 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
4.31 | 18665440 17276928 15929193 |
MESH:D006505 |
Hepatitis |
|
Caffeine |
14.29 | 11394713 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
14.29 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
14.29 | 16456712 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.73 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.45 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.47 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
7.47 | 12727271 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.24 | 16899240 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
10.81 | 14960337 1977408 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
10.81 | 16046005 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
5.27 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.27 | 17577099 15787275 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.80 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.29 | 18502941 12791704 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
3.06 | 4850670 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
4.86 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
4.86 | 9205823 17963957 17237260 17255318 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.78 | 16393666 16627594 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.36 | 17255318 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.32 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.32 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
6.58 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.58 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.22 | 16973256 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.40 | 15821434 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.75 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.65 | 16221502 17157831 17334410 16943688 17174718 21278145 11903743 16239168 11408273 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
marker/mechanism |
|
| 16783407 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Adenosine |
8.24 | 18263696 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.24 | 18418968 18472094 18187930 18395914 15876570 16248980 17525996 15931870 12741479 18210741 17640975 17922224 15362042 16638106 17708605 17714472 18156304 12898905 15730626 17805973 17761835 17557913 12958196 15338365 15673190 18412020 16192424 14748882 12632514 16136751 12667390 15818738 15123356 17869086 15996030 18472332 18339082 17481882 18429990 18251166 16027843 12546737 12632512 12649538 12445421 18376398 17766677 18277467 12586293 16116963 17631135 17565644 15052691 14724832 12445418 14716833 17944888 14620537 18205269 16011737 15959796 13678700 17900296 12666154 12609069 15057751 14716496 15370692 15925388 16015684 11481614 15650968 17698563 14512876 10355542 17823541 18317297 18395095 16033810 18006644 18705752 20821823 15893842 18263696 17721639 18166357 18054572 18279442 12389079 18481824 17976157 16097048 18420326 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.24 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
8.24 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
8.24 | 15893842 15931870 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
8.24 | 17629604 16126171 18458672 12531686 18295389 17127702 11682029 15078482 15288472 15288473 15474484 18032466 16343077 15316131 15158331 10677585 15095483 16489207 17355460 18263696 18031379 15334695 16248980 15075984 17292413 16098781 15716488 18416461 16511523 16097051 18380797 12679928 12557150 11481614 15362042 17050028 12175628 14739098 18606216 11172339 18615449 18395095 15465738 12891558 12085344 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.07 | 12969438 16610002 19460945 19784758 16611625 19014921 11587558 12587719 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.07 | 15720792 16964402 15830285 17285989 16246199 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
6.07 | 15158337 16337175 18374380 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.87 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
14.78 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
14.78 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
14.78 | 15313186 15633222 17276928 12479984 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
4.65 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
4.65 | 11940454 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.44 | 12014681 15583823 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.72 | 21114838 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.38 | 11807958 16891317 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.18 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.28 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
7.39 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
7.39 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.17 | 19142101 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.25 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.23 | 16497877 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.06 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.25 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.56 | 18551238 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.44 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.49 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.37 | 16427766 11399458 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.87 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
7.87 | 15183010 |
MESH:D009765 |
Obesity |
|
Clozapine |
2.94 | 18515891 19142110 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.17 | 12819281 16049721 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.21 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.96 | 17823083 15579764 15758505 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.13 | 19401270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.16 | 16870215 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.71 | 11181820 15451049 16510128 16140633 11124998 15824117 11445065 12911755 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.14 | 16190885 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
10.14 | 11605937 12224865 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
10.14 | 12504350 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.62 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.45 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.45 | 16536755 16220300 15731164 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.67 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.46 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
8.46 | 11575062 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.80 | 17997886 16324872 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.25 | 15770314 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.64 | 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Acetylcholine |
7.91 | 9413022 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
7.91 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.77 | 11874814 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.65 | 16458197 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.94 | 20107430 17667964 18855531 16141801 17726453 20452607 20168265 19369910 20580759 18806925 20521320 11763009 17123785 20521326 11151749 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
3.94 | 1830565 18513383 19369910 20107430 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.34 | 18551238 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.41 | 7327846 |
MESH:D012893 |
Sleep Disorders |
|
Caffeine |
5.02 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Caffeine |
4.80 | 17225163 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
6.12 | 1977408 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.59 | 16837676 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.43 | 20210726 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.91 | 15821434 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.71 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.71 | 19048282 |
MESH:D014202 |
Tremor |
|
istradefylline |
6.61 | 19467297 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
4.81 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
4.81 | 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.02 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.71 | 10982225 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.91 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.25 | 16343187 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.22 | 20564506 17502770 16141801 20107430 16402076 20521320 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.78 | 17933447 |